Published in Am J Obstet Gynecol on May 15, 1979
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med (1986) 2.18
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril (1993) 2.09
The polycystic ovary syndrome. Clin Endocrinol (Oxf) (1980) 1.84
Premenstrual syndrome. Am J Obstet Gynecol (1981) 1.80
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab (1994) 1.79
Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab (1974) 1.73
A simple method for the assay of eight steroids in small volumes of plasma. Steroids (1976) 1.69
Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab (1972) 1.59
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest (1976) 1.58
Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol (1990) 1.58
Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab (1970) 1.57
Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology (1999) 1.57
Pattern of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol (1977) 1.56
Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab (1985) 1.54
Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil Steril (1991) 1.51
Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol Metab (1968) 1.48
Treatment of endometriosis with the antiprogesterone mifepristone (RU486) Fertil Steril (1996) 1.48
Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med (1982) 1.46
The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) (1998) 1.45
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod (1999) 1.45
Pituitary apoplexy. A review. Arch Neurol (1985) 1.44
Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle. J Clin Endocrinol Metab (1972) 1.42
Hepres genitalis; clinical and cytopathologic experience with 256 patients. Obstet Gynecol (1970) 1.42
Obstetrics and gynecology-epitomes of progress: a new and effective treatment of hirsutism. West J Med (1981) 1.39
Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab (1983) 1.39
Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril (1982) 1.36
Chronological changes in sex steroid, gonadotropin and prolactin secretions in aging female rats displaying different reproductive states. Biol Reprod (1979) 1.35
Treatment of hirsutism with spironolactone. JAMA (1982) 1.34
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab (1996) 1.29
Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol (1974) 1.29
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab (1992) 1.26
The functional changes of the pituitary gonadotrophs during the menstrual cycle. J Clin Endocrinol Metab (1976) 1.25
Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. J Clin Endocrinol Metab (1989) 1.25
Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins. J Clin Endocrinol Metab (1993) 1.23
Inhibition of growth hormone release in humans by somatostatin. J Clin Endocrinol Metab (1973) 1.22
Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab (1997) 1.22
The estimation of pituitary luteinizing hormone secretion. J Clin Endocrinol Metab (1973) 1.21
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab (1992) 1.20
Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxf) (1985) 1.19
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J Clin Oncol (1987) 1.17
Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide. Cancer Res (1987) 1.16
Menopausal flushes: a neuroendocrine link with pulsatile luteninizing hormone secreation. Science (1979) 1.16
Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab (1997) 1.16
Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab (1993) 1.15
Totally implantable system for peritoneal access. J Clin Oncol (1984) 1.15
Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology (1981) 1.15
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect. Fertil Steril (1995) 1.14
Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab (1997) 1.13
Induction of ovulation and pregnancy with pulsatile luteinizing hormone releasing factor: dosage and mode of delivery. Fertil Steril (1981) 1.13
Modification of circadian body temperature rhythm during the luteal menstrual phase: role of melatonin. J Appl Physiol (1985) (1996) 1.12
Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab (1983) 1.11
The role of complement in feline endotoxin shock. Am J Obstet Gynecol (1972) 1.10
Gonorrhea during pregnancy. Obstet Gynecol (1968) 1.10
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women. J Clin Endocrinol Metab (1975) 1.09
Release of prostaglandins and histamine from sensitized and anaphylactic guinea pig lungs--changes in cyclic AMP levels. Biochem Pharmacol (1977) 1.09
Gonadotropin dynamics in patients with gonadal dysgenesis: a model for the study of gonadotropin regulation. J Clin Endocrinol Metab (1972) 1.09
The biology of menopause. J Reprod Med (1977) 1.09
beta-Endorphin in the human pancreas. J Clin Endocrinol Metab (1979) 1.08
Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. Am J Obstet Gynecol (1979) 1.08
Release of prostaglandins from healthy and sensitized guinea-pig lung and trachea by histamine. Prostaglandins (1976) 1.07
Modulation of pituitary responsiveness to LRF by estrogen. J Clin Endocrinol Metab (1974) 1.07
Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma. J Clin Endocrinol Metab (1980) 1.06
Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab (1994) 1.06
Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab (1998) 1.06
Augmented gonadotropin response to synthetic LRF in hypogonadal state. J Clin Endocrinol Metab (1973) 1.05
Acute effects of intravenous infusion of 17-beta-estradiol on gonadotropin release in pre- and post-menopausal women. J Clin Endocrinol Metab (1971) 1.04
A mid-day surge in cortisol levels. J Clin Endocrinol Metab (1979) 1.04
Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol (1990) 1.04
The premenstrual syndrome. Clin Obstet Gynecol (1983) 1.04
Indomethacin-responsive mononuclear cell dysfunction in "atypical" mycobacteriosis. Cell Immunol (1982) 1.04
Serum 17 beta-estradiol and estrone levels in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab (1976) 1.03
Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab (1993) 1.03
Simultaneous pulsatile release of prolactin and luteinizing hormone induced by luteinizing hormone-releasing factor agonist. J Clin Endocrinol Metab (1981) 1.03
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol (1975) 1.02
Synthetic luteinizing hormone-releasing factor. A potent stimulator of gonadotropin release in man. J Clin Endocrinol Metab (1972) 1.02
Absorption of estrogens from vaginal creams. N Engl J Med (1978) 1.01
Critique on the K-pyroantimonate method for semiquantitative estimation of cations in conjunction with electron microscopy. J Histochem Cytochem (1972) 1.01
beta-Endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab (1981) 1.01
Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. J Clin Endocrinol Metab (1996) 1.00
Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression. Arch Gen Psychiatry (1990) 0.99
Acute gonadotropin release induced by exogenous estradiol during the mid-follicular phase of the menstrual cycle. J Clin Endocrinol Metab (1972) 0.99
The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Am J Obstet Gynecol (1994) 0.98
Gonadotropin responses to synthetic LRF: dose-response relationship in men. J Clin Endocrinol Metab (1973) 0.98
Effect of anti-estrogenic action of clomiphene during the menstrual cycle: evidence for a change in the feedback sensitivity. J Clin Endocrinol Metab (1973) 0.98
Pulsatile patterns of gonadotropins and testosterone in man: the effects of clomiphene, with and without testosterone added. J Clin Endocrinol Metab (1973) 0.98
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab (1990) 0.98
Induction of midcycle gonadotropin surge by ovarian steroids in women: a critical evaluation. J Clin Endocrinol Metab (1983) 0.98
Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology (1999) 0.98
Circulating prolactin levels during the menstrual cycle: episodic release and diurnal variation. Am J Obstet Gynecol (1973) 0.98
The role of intravascular coagulation in feline endotoxin shock. Surg Gynecol Obstet (1972) 0.97
Amniotic fluid androgens and estrogens in midgestation. J Clin Endocrinol Metab (1977) 0.97
Release of histamine and formation of prostaglandins in human lung tissue and rat mast cells. Int Arch Allergy Appl Immunol (1977) 0.97
Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. Hum Reprod (1994) 0.96
Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab (1989) 0.96
Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab (1973) 0.96
Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism. Am J Obstet Gynecol (1977) 0.96
Serum complement in normal pregnancy and pre-eclampsia. Am J Obstet Gynecol (1973) 0.96